Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Public Health England (PHE) has awarded a contract to Cambridge Life Sciences to procure combined IgG/IgM ELISA kits suitable for screening Human Sera (and potentially CSF) from suspected Lyme disease patients.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Cambridge Life Sciences | 04897864 | £400,000 | - |